{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:53:43Z","timestamp":1786737223230,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/0028-3886.284361","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T03:56:51Z","timestamp":1589515011000},"page":"478","source":"Crossref","is-referenced-by-count":9,"title":["A Case of High Grade Glioma Following Treatment of Relapsing-Remitting Multiple Sclerosis with Fingolimod"],"prefix":"10.4103","volume":"68","author":[{"given":"Ozden","family":"Kamisli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MehmetFatih","family":"Erbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.284361-1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.clinthera.2015.03.001","article-title":"New FDA-approved disease-modifying therapies for multiple sclerosis","author":"English","year":"2015","journal-title":"Clin Ther"},{"key":"key-10.4103\/0028-3886.284361-2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4149\/BLL_2018_035","article-title":"New biological agents in the treatment of multiple sclerosis","author":"Buc","year":"2018","journal-title":"Bratisl Med J"},{"key":"key-10.4103\/0028-3886.284361-3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.msard.2018.11.025","article-title":"Listeria monocytogenes rhombencephalitis in a patient with multiple sclerosis during fingolimod therapy","author":"Tecellioglu","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"key-10.4103\/0028-3886.284361-4","first-page":"15","article-title":"Recent advances in the treatment for multiple sclerosis; Current new drugs specific for multiple sclerosis","author":"Taskapilioglu","year":"2018","journal-title":"Noro Psikiyatr Ars"},{"key":"key-10.4103\/0028-3886.284361-5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clineuro.2005.11.015","article-title":"Anaplastic oligodendroglioma and gliomatosis type 2 in interferon-beta treated multiple sclerosis patients.Report of two cases","author":"Sega","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"key-10.4103\/0028-3886.284361-6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/01.wnl.0000345366.10455.62","article-title":"Cancer risk among patients with multiple sclerosis and their parents","author":"Bahmanyar","year":"2009","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.284361-7","first-page":"40","article-title":"Concurrence of multiple sclerosis and brain tumors","author":"Plantone","year":"2015","journal-title":"Front Neurol"},{"key":"key-10.4103\/0028-3886.284361-8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.msard.2018.12.022","article-title":"Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases","author":"Codjia","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"key-10.4103\/0028-3886.284361-9","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3174\/ajnr.A5775","article-title":"MRI findings in tumefactive demyelinating lesions: A systematic review and meta-analysis","author":"Suh","year":"2018","journal-title":"Am J Neuroradiol"},{"key":"key-10.4103\/0028-3886.284361-10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.msard.2015.07.013","article-title":"Neuro-oncology dilemma: Tumour or tumefactive demyelinating lesion","author":"Abdoli","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"key-10.4103\/0028-3886.284361-11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3174\/ajnr.A5089","article-title":"Combining diffusion tensor metrics and DSC perfusion imaging: Can it improve the diagnostic accuracy in differentiating tumefactive demyelination from high-grade glioma?","author":"Hiremath","year":"2017","journal-title":"Am J Neuroradiol"},{"key":"key-10.4103\/0028-3886.284361-12","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1177\/1352458512445407","article-title":"Acute demyelinating lesions with restricted diffusion in multiple sclerosis","author":"Balashov","year":"2012","journal-title":"Mult Scler"},{"key":"key-10.4103\/0028-3886.284361-13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3174\/ajnr.A2871","article-title":"Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging","author":"Toh","year":"2012","journal-title":"Am J Neuroradiol"},{"key":"key-10.4103\/0028-3886.284361-14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jocn.2016.02.003","article-title":"Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis","author":"Sharim","year":"2016","journal-title":"J Clin Neurosci"},{"key":"key-10.4103\/0028-3886.284361-15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s40263-018-0564-y","article-title":"Cancer risk in patients with multiple sclerosis: Potential impact of disease-modifying drugs","author":"Lebrun","year":"2018","journal-title":"CNS Drugs"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:51:44Z","timestamp":1786733504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.284361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["284361"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.284361","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}